Crossmark

Targeting MDM2-mediated suppression of p53 with idasanutlin: a promising therapeutic approach for acute lymphoblastic leukemia

Published Online: 2024-09-21

Published Print: 2024-12

Authors

Gungordu, Seyda

Aptullahoglu, Erhan
Funding

Funding for this research was provided by:

Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (121S986)
License Information

Text and Data Mining valid from 2024-09-21

Version of Record valid from 2024-09-21
More Information

Article History

Received: 17 July 2024

Accepted: 17 September 2024

First Online: 21 September 2024

Declarations

:

: The authors declare no competing interests.

Document is current